These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8558918

  • 1. Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.
    Mohammad RM, Mohamed AN, Hamdan MY, Vo T, Chen B, Katato K, Abubakr YA, Dugan MC, al-Katib A.
    Leukemia; 1996 Jan; 10(1):130-7. PubMed ID: 8558918
    [Abstract] [Full Text] [Related]

  • 2. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM, Katato K, Almatchy VP, Wall N, Liu KZ, Schultz CP, Mantsch HH, Varterasian M, al-Katib AM.
    Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
    Mohammad RM, Varterasian ML, Almatchy VP, Hannoudi GN, Pettit GR, Al-Katib A.
    Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595
    [Abstract] [Full Text] [Related]

  • 4. Engraftment of human chronic lymphocytic leukemia cells in SCID mice: in vivo and in vitro studies.
    Hummel JL, Lichty BD, Reis M, Dubé I, Kamel-Reid S.
    Leukemia; 1996 Aug; 10(8):1370-6. PubMed ID: 8709647
    [Abstract] [Full Text] [Related]

  • 5. Establishment of a novel human B-CLL-like xenograft model in nude mouse.
    Loisel S, Ster KL, Quintin-Roue I, Pers JO, Bordron A, Youinou P, Berthou C.
    Leuk Res; 2005 Nov; 29(11):1347-52. PubMed ID: 15896841
    [Abstract] [Full Text] [Related]

  • 6. Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.
    Mohammad RM, Dugan MC, Mohamed AN, Almatchy VP, Flake TM, Dergham ST, Shields AF, Al-Katib AA, Vaitkevicius VK, Sarkar FH.
    Pancreas; 1998 Jan; 16(1):19-25. PubMed ID: 9436858
    [Abstract] [Full Text] [Related]

  • 7. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
    Dürig J, Ebeling P, Grabellus F, Sorg UR, Möllmann M, Schütt P, Göthert J, Sellmann L, Seeber S, Flasshove M, Dührsen U, Moritz T.
    Cancer Res; 2007 Sep 15; 67(18):8653-61. PubMed ID: 17875705
    [Abstract] [Full Text] [Related]

  • 8. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
    Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, de Frias M, Roué G, Gil J, Colomer D, Campanero MA, Blanco-Prieto MJ.
    Clin Cancer Res; 2010 Apr 01; 16(7):2046-54. PubMed ID: 20233887
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine.
    Mohammad RM, Limvarapuss C, Hamdy N, Dutcher BS, Beck FW, Wall NR, Al-Katib AM.
    Int J Oncol; 1999 May 01; 14(5):945-50. PubMed ID: 10200346
    [Abstract] [Full Text] [Related]

  • 11. Establishment and characterization of the tumors of chronic lymphocytic leukemia cell line in nude and SCID mice.
    Kawata A, Han T, Dadey B, Weier HU, Okazaki M, Yokota S, Fukiage T, Xiao H, Block AM, Barcos M.
    Leuk Res; 1993 Oct 01; 17(10):883-94. PubMed ID: 8412300
    [Abstract] [Full Text] [Related]

  • 12. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
    Shimoni A, Marcus H, Dekel B, Shkarchi R, Arditti F, Shvidel L, Shtalrid M, Bucher W, Canaan A, Ergas D, Berrebi A, Reisner Y.
    Cancer Res; 1999 Dec 01; 59(23):5968-74. PubMed ID: 10606243
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E, Norberg M, Kanduri M, Tobin G, Säisänen L, Aberg M, Gustafsson MG, Sundström C, Rosenquist R, Aleskog A.
    Eur J Haematol; 2009 Jul 01; 83(1):22-34. PubMed ID: 19245531
    [Abstract] [Full Text] [Related]

  • 19. Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemia.
    de Kroon JF, Kluin-Nelemans HC, Kluin PM, Schuuring E, van Bergen CA, Oving I, Wessels H, Willemze R, Falkenburg JH.
    Exp Hematol; 1997 Sep 01; 25(10):1062-8. PubMed ID: 9293903
    [Abstract] [Full Text] [Related]

  • 20. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
    Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A.
    Clin Cancer Res; 2002 Apr 01; 8(4):1277-83. PubMed ID: 11948143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.